Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calmodulin-dependent phosphodiesterase
(
CaM-PDE
) is selectively expressed in specific neuronal populations in adult rat brain. In cerebellar cortex, it is expressed at high levels in Purkinje cells (soma and dendrites). Climbing fiber ablation by intraperitoneal injections of 3-acetylpyridine resulted in a selective
depression
of cerebellar
CaM-PDE
expression using Western immunoblot procedures; neither calcineurin (calmodulin-dependent protein phosphatase) nor other calmodulin binding proteins, detected by biotinylated calmodulin overlays, were affected. Immunocytochemical staining of cerebellum revealed a loss of detectable
CaM-PDE
immunoreactivity in Purkinje cells, with no appreciable change in calcineurin immunoreactivity. Cerebral cortex was examined as a control for a direct effect of 3-acetylpyridine on
CaM-PDE
expression, independent of climbing fiber deafferentation. There were no detectable changes in
CaM-PDE
or calcineurin immunoreactivity in cortical pyramidal cells, and no changes were detected, either in Western blot analyses for
CaM-PDE
or calcineurin or in biotinylated calmodulin overlays. These data suggest that
CaM-PDE
expression in Purkinje cells is regulated transsynaptically by climbing fiber inputs.
...
PMID:Evidence for transsynaptic regulation of calmodulin-dependent cyclic nucleotide phosphodiesterase in cerebellar Purkinje cells. 274 32